Compare ARK Genomic Revolution ETF (ARKG) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Tilray Brands Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.88, while Tilray Brands Inc trades at $4.78 (market cap $649.42M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | TLRY | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $44.55 | $21.00 |
52-Week Low | $24.02 | $3.88 |
Market Cap | — | $649.42M |
Enterprise Value | — | $816.55M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
